https://ozemback.com Independent editorial coverage of GLP-1 medications, metabolic health, and body culture. en https://ozemback.com/assets/brand/logo-forest-on-transparent.png https://ozemback.com https://ozemback.com/blog/ozempic-personality-what-science-says/ https://ozemback.com/blog/ozempic-personality-what-science-says/ 2026-04-30T00:00:00Z GLP-1 https://ozemback.com/blog/retatrutide-glp3-what-we-know/ https://ozemback.com/blog/retatrutide-glp3-what-we-know/ 2026-04-29T00:00:00Z GLP-1 https://ozemback.com/blog/orforglipron-first-glp1-pill-2026/ https://ozemback.com/blog/orforglipron-first-glp1-pill-2026/ 2026-04-30T00:00:00Z GLP-1 https://ozemback.com/blog/fda-peptide-reclassification-2026/ https://ozemback.com/blog/fda-peptide-reclassification-2026/ 2026-04-30T00:00:00Z GLP-1 https://ozemback.com/blog/the-third-way-cultural-essay/ https://ozemback.com/blog/the-third-way-cultural-essay/ 2026-05-28T00:00:00Z GLP-1 https://ozemback.com/blog/retatrutide-phase-3-five-numbers-everyone-ignoring/ https://ozemback.com/blog/retatrutide-phase-3-five-numbers-everyone-ignoring/ 2026-05-29T00:00:00Z GLP-1 https://ozemback.com/blog/discontinuation-rates-data-press-release-skipped/ https://ozemback.com/blog/discontinuation-rates-data-press-release-skipped/ 2026-06-08T00:00:00Z GLP-1 https://ozemback.com/blog/cardiovascular-outcomes-select-trial-closer-read/ https://ozemback.com/blog/cardiovascular-outcomes-select-trial-closer-read/ 2026-06-10T00:00:00Z GLP-1 https://ozemback.com/blog/fda-feb-2026-peptide-reclassification-piece-by-piece/ https://ozemback.com/blog/fda-feb-2026-peptide-reclassification-piece-by-piece/ 2026-06-12T00:00:00Z GLP-1 https://ozemback.com/blog/compounded-glp1-crackdown-actual-timeline-actual-losses/ https://ozemback.com/blog/compounded-glp1-crackdown-actual-timeline-actual-losses/ 2026-06-15T00:00:00Z GLP-1 https://ozemback.com/blog/orforglipron-approval-timeline-what-we-know/ https://ozemback.com/blog/orforglipron-approval-timeline-what-we-know/ 2026-06-19T00:00:00Z GLP-1 https://ozemback.com/blog/fda-suicidality-signal-2023-still-unresolved/ https://ozemback.com/blog/fda-suicidality-signal-2023-still-unresolved/ 2026-06-22T00:00:00Z GLP-1 https://ozemback.com/blog/step-4-trial-what-nobody-quotes-correctly/ https://ozemback.com/blog/step-4-trial-what-nobody-quotes-correctly/ 2026-06-05T00:00:00Z GLP-1 https://ozemback.com/blog/body-composition-data-buried-surmount-trials/ https://ozemback.com/blog/body-composition-data-buried-surmount-trials/ 2026-06-01T00:00:00Z GLP-1 https://ozemback.com/blog/dea-shadow-over-peptide-reclassification/ https://ozemback.com/blog/dea-shadow-over-peptide-reclassification/ 2026-06-24T00:00:00Z GLP-1